Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
The familial nature of MS.

Neurology

Sadovnick AD.
PMID: 6681553
Neurology. 1983 Jan;33(1):117. doi: 10.1212/wnl.33.1.117.

No abstract available.

Cite
Sadovnick AD. The familial nature of MS. Neurology. 1983;33(1):117doi: 10.1212/wnl.33.1.117.
Sadovnick, A. D. (1983). The familial nature of MS. Neurology, 33(1), 117. https://doi.org/10.1212/wnl.33.1.117
Sadovnick, A D. "The familial nature of MS." Neurology vol. 33,1 (1983): 117. doi: https://doi.org/10.1212/wnl.33.1.117
Sadovnick AD. The familial nature of MS. Neurology. 1983 Jan;33(1):117. doi: 10.1212/wnl.33.1.117. PMID: 6681553.
Copy Download .nbib Format: NLM
The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients.

Neurology

Sadovnick AD, Macleod PM.
PMID: 7196517
Neurology. 1981 Aug;31(8):1039-41. doi: 10.1212/wnl.31.8.1039.

Although the risks are low, relatives of multiple sclerosis (MS) patients have a greater risk of developing the disease than the general population. Since this is true of second- and third-degree relatives as well as first-degree relatives, the increased...

Cite
Sadovnick AD, Macleod PM. The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients. Neurology. 1981;31(8):1039-41doi: 10.1212/wnl.31.8.1039.
Sadovnick, A. D., & Macleod, P. M. (1981). The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients. Neurology, 31(8), 1039-41. https://doi.org/10.1212/wnl.31.8.1039
Sadovnick, A D, and Macleod, P M. "The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients." Neurology vol. 31,8 (1981): 1039-41. doi: https://doi.org/10.1212/wnl.31.8.1039
Sadovnick AD, Macleod PM. The familial nature of multiple sclerosis: empiric recurrence risks for first, second-, and third-degree relatives of patients. Neurology. 1981 Aug;31(8):1039-41. doi: 10.1212/wnl.31.8.1039. PMID: 7196517.
Copy Download .nbib Format: NLM
Current concepts in multiple sclerosis: Part I.

South Dakota journal of medicine

Hanson LJ, Cafruny WA.
PMID: 12422797
S D J Med. 2002 Oct;55(10):433-6.

Multiple sclerosis (MS) is a complex and challenging autoimmune disease of the central nervous system, affecting approximately 0.1% of the US population. Evidence to date suggests that viral infection triggers autoimmune attack against nerve cells in genetically-susceptible individuals. Neurologic...

Cite
Hanson LJ, Cafruny WA. Current concepts in multiple sclerosis: Part I. S D J Med. 2002;55(10):433-6
Hanson, L. J., & Cafruny, W. A. (2002). Current concepts in multiple sclerosis: Part I. South Dakota journal of medicine, 55(10), 433-6.
Hanson, Linda J, and Cafruny, William A. "Current concepts in multiple sclerosis: Part I." South Dakota journal of medicine vol. 55,10 (2002): 433-6.
Hanson LJ, Cafruny WA. Current concepts in multiple sclerosis: Part I. S D J Med. 2002 Oct;55(10):433-6. PMID: 12422797.
Copy Download .nbib Format: NLM
The genetics of multiple sclerosis.

Journal of neurovirology

Compston A.
PMID: 10871776
J Neurovirol. 2000 May;6:S5-9.

Epidemiological studies implicate an interplay between genetic and environmental factors in the aetiology of multiple sclerosis. The classical genetic observations suggest that multiple sclerosis is a complex trait in which susceptibility is determined by several genes acting independently or...

Cite
Compston A. The genetics of multiple sclerosis. J Neurovirol. 2000;6:S5-9
Compston, A. (2000). The genetics of multiple sclerosis. Journal of neurovirology, 6S5-9.
Compston, A. "The genetics of multiple sclerosis." Journal of neurovirology vol. 6 (2000): S5-9.
Compston A. The genetics of multiple sclerosis. J Neurovirol. 2000 May;6:S5-9. PMID: 10871776.
Copy Download .nbib Format: NLM
An insight about genomic susceptibility & multiple sclerosis.

The Indian journal of medical research

Verma R, Singh N.
PMID: 29067970
Indian J Med Res. 2017 Jun;145(6):713-714. doi: 10.4103/ijmr.IJMR_725_17.

No abstract available.

Cite
Verma R, Singh N. An insight about genomic susceptibility & multiple sclerosis. Indian J Med Res. 2017;145(6):713-714doi: 10.4103/ijmr.IJMR_725_17.
Verma, R., & Singh, N. (2017). An insight about genomic susceptibility & multiple sclerosis. The Indian journal of medical research, 145(6), 713-714. https://doi.org/10.4103/ijmr.IJMR_725_17
Verma, Rajesh, and Singh, Neetu. "An insight about genomic susceptibility & multiple sclerosis." The Indian journal of medical research vol. 145,6 (2017): 713-714. doi: https://doi.org/10.4103/ijmr.IJMR_725_17
Verma R, Singh N. An insight about genomic susceptibility & multiple sclerosis. Indian J Med Res. 2017 Jun;145(6):713-714. doi: 10.4103/ijmr.IJMR_725_17. PMID: 29067970; PMCID: PMC5674538.
Copy Download .nbib Format: NLM
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.

Neuron

[No authors listed]
PMID: 27764667
Neuron. 2016 Oct 19;92(2):333-335. doi: 10.1016/j.neuron.2016.09.052.

A recent study by Wang et al. (2016a) claims that the low-frequency variant NR1H3 p.Arg415Gln is sufficient to cause multiple sclerosis in certain individuals and determines a patient's likelihood of primary progressive disease. We sought to replicate this finding...

Cite
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk. Neuron. 2016;92(2):333-335doi: 10.1016/j.neuron.2016.09.052.
(2016). NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk. Neuron, 92(2), 333-335. https://doi.org/10.1016/j.neuron.2016.09.052
"NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk." Neuron vol. 92,2 (2016): 333-335. doi: https://doi.org/10.1016/j.neuron.2016.09.052
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk. Neuron. 2016 Oct 19;92(2):333-335. doi: 10.1016/j.neuron.2016.09.052. PMID: 27764667; PMCID: PMC5641967.
Copy Download .nbib Format: NLM
The epidemiology of multiple sclerosis.

Acta neurologica Scandinavica. Supplementum

Martyn CN, Gale CR.
PMID: 9174634
Acta Neurol Scand Suppl. 1997;169:3-7. doi: 10.1111/j.1600-0404.1997.tb08143.x.

No abstract available.

Cite
Martyn CN, Gale CR. The epidemiology of multiple sclerosis. Acta Neurol Scand Suppl. 1997;169:3-7doi: 10.1111/j.1600-0404.1997.tb08143.x.
Martyn, C. N., & Gale, C. R. (1997). The epidemiology of multiple sclerosis. Acta neurologica Scandinavica. Supplementum, 1693-7. https://doi.org/10.1111/j.1600-0404.1997.tb08143.x
Martyn, C N, and Gale, C R. "The epidemiology of multiple sclerosis." Acta neurologica Scandinavica. Supplementum vol. 169 (1997): 3-7. doi: https://doi.org/10.1111/j.1600-0404.1997.tb08143.x
Martyn CN, Gale CR. The epidemiology of multiple sclerosis. Acta Neurol Scand Suppl. 1997;169:3-7. doi: 10.1111/j.1600-0404.1997.tb08143.x. PMID: 9174634.
Copy Download .nbib Format: NLM
The role of epidemiology in MS research: Past successes, current challenges and future potential.

Multiple sclerosis (Houndmills, Basingstoke, England)

Simpson S, Taylor BV, van der Mei I.
PMID: 25767125
Mult Scler. 2015 Jul;21(8):969-77. doi: 10.1177/1352458515574896. Epub 2015 Mar 12.

Multiple sclerosis (MS) is a multifaceted condition, with a range of environmental, behavioural and genetic factors implicated in its aetiology and clinical course. Successes in advancing our appreciation of the roles of Epstein-Barr virus, vitamin D/UV and the HLA-DRB1...

Cite
Simpson S, Taylor BV, van der Mei I. The role of epidemiology in MS research: Past successes, current challenges and future potential. Mult Scler. 2015;21(8):969-77doi: 10.1177/1352458515574896.
Simpson, S., Taylor, B. V., & van der Mei, I. (2015). The role of epidemiology in MS research: Past successes, current challenges and future potential. Multiple sclerosis (Houndmills, Basingstoke, England), 21(8), 969-77. https://doi.org/10.1177/1352458515574896
Simpson, Steve, et al. "The role of epidemiology in MS research: Past successes, current challenges and future potential." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 21,8 (2015): 969-77. doi: https://doi.org/10.1177/1352458515574896
Simpson S, Taylor BV, van der Mei I. The role of epidemiology in MS research: Past successes, current challenges and future potential. Mult Scler. 2015 Jul;21(8):969-77. doi: 10.1177/1352458515574896. Epub 2015 Mar 12. PMID: 25767125.
Copy Download .nbib Format: NLM
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?.

Expert review of neurotherapeutics

Dobson R, Ramagopalan SV, Giovannoni G.
PMID: 23448211
Expert Rev Neurother. 2013 Mar;13(3):235-7. doi: 10.1586/ern.13.13.

No abstract available.

Cite
Dobson R, Ramagopalan SV, Giovannoni G. Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. Expert Rev Neurother. 2013;13(3):235-7doi: 10.1586/ern.13.13.
Dobson, R., Ramagopalan, S. V., & Giovannoni, G. (2013). Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. Expert review of neurotherapeutics, 13(3), 235-7. https://doi.org/10.1586/ern.13.13
Dobson, Ruth, et al. "Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?." Expert review of neurotherapeutics vol. 13,3 (2013): 235-7. doi: https://doi.org/10.1586/ern.13.13
Dobson R, Ramagopalan SV, Giovannoni G. Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. Expert Rev Neurother. 2013 Mar;13(3):235-7. doi: 10.1586/ern.13.13. PMID: 23448211.
Copy Download .nbib Format: NLM
Multiple sclerosis genetics.

Multiple sclerosis (Houndmills, Basingstoke, England)

Canto E, Oksenberg JR.
PMID: 29307290
Mult Scler. 2018 Jan;24(1):75-79. doi: 10.1177/1352458517737371.

A broad scientific consensus has emerged linking multiple sclerosis (MS) risk to multiple independent and interacting DNA variants that are relatively frequent in the population and act in concert with environmental exposures. The multifactorial, polygenic model of heritability provided...

Cite
Canto E, Oksenberg JR. Multiple sclerosis genetics. Mult Scler. 2018;24(1):75-79doi: 10.1177/1352458517737371.
Canto, E., & Oksenberg, J. R. (2018). Multiple sclerosis genetics. Multiple sclerosis (Houndmills, Basingstoke, England), 24(1), 75-79. https://doi.org/10.1177/1352458517737371
Canto, Ester, and Oksenberg, Jorge R. "Multiple sclerosis genetics." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24,1 (2018): 75-79. doi: https://doi.org/10.1177/1352458517737371
Canto E, Oksenberg JR. Multiple sclerosis genetics. Mult Scler. 2018 Jan;24(1):75-79. doi: 10.1177/1352458517737371. PMID: 29307290.
Copy Download .nbib Format: NLM
How do we measure the epigenome(s)?.

Multiple sclerosis (Houndmills, Basingstoke, England)

Klein HU, De Jager PL.
PMID: 29722595
Mult Scler. 2018 Apr;24(4):446-448. doi: 10.1177/1352458517750772.

No abstract available.

Cite
Klein HU, De Jager PL. How do we measure the epigenome(s)?. Mult Scler. 2018;24(4):446-448doi: 10.1177/1352458517750772.
Klein, H. U., & De Jager, P. L. (2018). How do we measure the epigenome(s)?. Multiple sclerosis (Houndmills, Basingstoke, England), 24(4), 446-448. https://doi.org/10.1177/1352458517750772
Klein, Hans-Ulrich, and De Jager, Philip L. "How do we measure the epigenome(s)?." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24,4 (2018): 446-448. doi: https://doi.org/10.1177/1352458517750772
Klein HU, De Jager PL. How do we measure the epigenome(s)?. Mult Scler. 2018 Apr;24(4):446-448. doi: 10.1177/1352458517750772. PMID: 29722595.
Copy Download .nbib Format: NLM
Evaluating the role of genetic variation in the epigenome in health and disease.

Multiple sclerosis (Houndmills, Basingstoke, England)

Roostaei T, De Jager PL.
PMID: 29790436
Mult Scler. 2018 May;24(6):707-709. doi: 10.1177/1352458517751651.

No abstract available.

Cite
Roostaei T, De Jager PL. Evaluating the role of genetic variation in the epigenome in health and disease. Mult Scler. 2018;24(6):707-709doi: 10.1177/1352458517751651.
Roostaei, T., & De Jager, P. L. (2018). Evaluating the role of genetic variation in the epigenome in health and disease. Multiple sclerosis (Houndmills, Basingstoke, England), 24(6), 707-709. https://doi.org/10.1177/1352458517751651
Roostaei, Tina, and De Jager, Philip L. "Evaluating the role of genetic variation in the epigenome in health and disease." Multiple sclerosis (Houndmills, Basingstoke, England) vol. 24,6 (2018): 707-709. doi: https://doi.org/10.1177/1352458517751651
Roostaei T, De Jager PL. Evaluating the role of genetic variation in the epigenome in health and disease. Mult Scler. 2018 May;24(6):707-709. doi: 10.1177/1352458517751651. PMID: 29790436.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries